
Rita Mendes
@rita_smendes
๐ธBiotech Venture Creation
๐ธCo-Founder @om_science
๐ธ PhD in Bioengineering MIT-Portugal
ID: 1309746475354722307
26-09-2020 06:48:03
47 Tweet
46 Followers
237 Following

NEW Review from Ayelet Erez & colleagues discusses reprogramming of the #UreaCycle in #cancer cells. What are the metabolic advantages and therapeutic opportunities stemming from urea cycle dysfunction in cancer? #CancerMetabolism go.nature.com/2NnEvdg


๐ ๐๐ฎ๐ฐ๐ถ๐ป๐ฎ ๐ฝ๐ฎ๐ฟ๐ฎ ๐ฎ ๐๐ข๐ฉ๐๐-๐ญ๐ต ๐ฒฬ ๐๐ฒ๐ด๐๐ฟ๐ฎ? @MigPrudencio, parasitologista, explica-nos porque razรฃo as vacinas #COVID19 sรฃo seguras. Sexta-feira, dia 8 ร s 18h, os quatro cientistas vรฃo responder ร s suas dรบvidas em direto no YouTube ๐ bit.ly/YouTubeiMM




Very happy to see Afekta Technologies among the world top 5 #metabolomics #startups as evaluated by StartUs Insights ๐๐๐ป startus-insights.com/innovators-guiโฆ



First PhD paper is finally out ๐ Springer Nature, check it here rdcu.be/cxWUu ๐ #oncology #exvivomodels #preclinicalresearch


Yesterday I became Doctor Mendes, such an happy feeling! And one of my best friends became today Doctor F. Coelho! So proud of us my friend Lรญgia Fonseca Coelho ๐ต๐น๐บ๐ฒ โค๏ธ #PhDone

The main paper of my PhD is just out! #biomarkers #oncology #drugefficacy mdpi.com/1829342 #mdpicancers via Cancers MDPI


The most controversial meta-analysis of the year is now published on The Lancet. Anthracyclines improved outcomes when added to adjuvant taxanes, but only when administered concurrently. No apparent benefit for sequential schedules, which are current SoC. thelancet.com/journals/lanceโฆ

